CLOV today
$4.96+$0.08 (+1.64%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourBullish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns down below $4.19
Key levels
Resistance$5.59
Resistance$5.28
Support$4.86
Support$4.52
Latest news & SEC filings
EarningsClover Health posts Q3 2026 results, lifts guidance
SEC FilingClover Health Investments, Corp. filed an insider trading report (Form 4)
AnalystUBS keeps Neutral rating on Clover Health, lifts price target to $5.5
All CLOV news →About Clover Health
Clover Health is a Medicare Advantage insurer offering PPO and HMO plans to Medicare-eligible seniors, including those in underserved communities. It develops its own software, Clover Assistant, which supplies physicians with data-driven clinical insights during visits, and licenses the technology to outside payors and providers through Counterpart Health. The company also delivers in-home medical care for members with complex conditions and operates in several states.
Based on the company's 10-K filed Feb 27, 2026.
Nasdaq · Healthcare
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
What Is the Price Target for CLOV?
SEPT Low Target
$5.00
SEPT Mid Target
$5.50
SEPT High Target
$6.00
Analyst Consensus
$5.50
Is CLOV a Buy or Sell Right Now?
Thesis
- •Revenue growing 40.3% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CLOV.
Start Free Trial →Is CLOV Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$4.12
22
Moat Score
NONE
2/9
Piotroski Score
3.0
Altman Z-Score
What Is Smart Money Doing with CLOV?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| OLDAKOWSKI JOSEPH FRANK | officer | Buy | 186,403 | - | Nov 4, 2026 |
| THORNTON JOSEPH CLAY | officer | Buy | 328,947 | - | Nov 4, 2026 |
| Soares Karen | officer | Sale | 19,275 | $90K | Oct 20, 2026 |
| Reynoso Jamie L. | officer | Sale | 4,066 | $18K | Oct 19, 2026 |
| Reynoso Jamie L. | officer | Sale | 2,006 | $9K | Oct 7, 2026 |
| Reynoso Jamie L. | officer | Sale | 8,750 | $39K | Oct 5, 2026 |
| Torricelli Robert G | director | Buy | 12,481 | - | Sep 30, 2026 |
| Reynoso Jamie L. | officer | Sale | 1,921 | $9K | Sep 17, 2026 |
| Reynoso Jamie L. | officer | Sale | 7,289 | $36K | Jun 11, 2026 |
| Wai Conrad | officer | Sale | 220,426 | $879K | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CLOV Growth Story
Revenue YoY
40.3%
3yr Revenue CAGR
20.6%
EPS Growth YoY
-88.89%
FCF Growth YoY
-307.2%
Revenue Trend
ACCELERATING
Dark Pool Trades for CLOV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CLOV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:59:43 | $4.92 | 1,200 | $$6K | SELL |
| 22:21:50 | $4.87 | 20,000 | $$97K | SELL |
| 22:21:03 | $4.87 | 9,250 | $$45K | SELL |
| 22:19:31 | $4.87 | 3,250 | $$16K | SELL |
| 21:28:39 | $4.96 | 631,440 | $$3.1M | BUY |
5 dark pool trades shown · $$3.3M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for CLOV
PREVIEWSEPT Investing provides real-time options flow tracking for CLOV, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $4.5 | Nov 20 | 7 | $$4 | 1 | SWEEP |
| PUT | $5 | Nov 20 | 7 | $$22 | 1 | SWEEP |
| PUT | $4.5 | Nov 20 | 7 | $$20 | 5 | SWEEP |
| PUT | $4.5 | Nov 20 | 7 | $$4 | 1 | SWEEP |
| PUT | $5 | Nov 20 | 7 | $$110 | 5 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CLOV — frequently asked questions
What is CLOV stock price today?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) is at $4.96, up 1.64% (+$0.08) at the Nov 13, 2026 close.
Why is CLOV stock moving today?
Latest CLOV news — Nov 9, 2026: Clover Health posts Q3 2026 results, lifts guidance · Nov 6, 2026: Clover Health Investments, Corp. filed an insider trading report (Form 4)
What is the CLOV price target?
The average analyst price target for CLOV is $5.50, ranging from $5 to $6, based on 4 analysts. Latest: Needham initiates on Oct 28, 2026.
What do analysts rate CLOV?
Analyst ratings for CLOV: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did CLOV beat earnings?
CLOV last reported on Aug 5, 2026: EPS $0.05 vs $0.04 expected — a beat of 29.5%.
Does CLOV pay a dividend?
CLOV does not currently pay a dividend.
What are CLOV support and resistance levels?
Support: $4.86, $4.52, $4.19. Resistance: $5.28, $5.59, $6.52.
What are insiders doing with CLOV?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on CLOV?
Nov 9, 2026: Clover Health posts Q3 2026 results, lifts guidance · Nov 6, 2026: Clover Health Investments, Corp. filed an insider trading report (Form 4) · Nov 5, 2026: UBS keeps Neutral rating on Clover Health, lifts price target to $5.5